Stanozolol 25 - Gen-Shi Laboratories

Clinical interest in Stanozolol surged after its 1962 release as Winstrol, a product of Winthrop Laboratories. Designed to counteract wasting and delayed growth, it combined oral activity with minimal androgenic traits. Its unique pyrazole-modified DHT structure made it a non-aromatizing anabolic agent, well-suited for lean mass retention. Though eventually delisted in the U.S., it gained longevity through veterinary channels and remains legally produced in several countries, especially in injectable forms used in equine and livestock therapy.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Stanozolol 25 by Gen-Shi Laboratories, consult with your doctor or healthcare professional.